Genetics |
Complete Genome Sequence of Mycobacterium avium subsp. avium Chester (DSM 44156). |
Goethe R, Laarmann K, Sproer C, Bunk B |
Microbiol Resour Announc |
10.1128/MRA.01549-19 |
2020 |
* |
Phylogeny |
A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review. |
van Ingen J, Turenne CY, Tortoli E, Wallace RJ Jr, Brown-Elliott BA |
Int J Syst Evol Microbiol |
10.1099/ijsem.0.003026 |
2018 |
* |
Pathogenicity |
Comparison of chlorine dioxide and dichloroisocyanurate disinfectants for use in the dental setting. |
Patel M, Ebonwu J, Cutler E |
SADJ |
|
2012 |
* |
Pathogenicity |
Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. |
Luo X, Pires D, Ainsa JA, Gracia B, Mulhovo S, Duarte A, Anes E, Ferreira MJ |
J Ethnopharmacol |
10.1016/j.jep.2011.04.062 |
2011 |
* |
Pathogenicity |
Growth of M. avium subspecies paratuberculosis in culture is enhanced by nicotinic acid, nicotinamide, and alpha and beta nicotinamide adenine dinucleotide. |
Greenstein RJ, Su L, Brown ST |
Dig Dis Sci |
10.1007/s10620-010-1301-7 |
2010 |
* |
Metabolism |
Fucosyltransferase IV and VII-directed selectin ligand function determines long-term survival in experimental tuberculosis. |
Ehlers S, Schreiber T, Dunzendorfer A, Lowe JB, Holscher C |
Immunobiology |
10.1016/j.imbio.2008.12.009 |
2009 |
* |
Pathogenicity |
On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. |
Greenstein RJ, Su L, Juste RA, Brown ST |
PLoS One |
10.1371/journal.pone.0002496 |
2008 |
* |
Metabolism |
Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. |
Rodrigues L, Wagner D, Viveiros M, Sampaio D, Couto I, Vavra M, Kern WV, Amaral L |
J Antimicrob Chemother |
10.1093/jac/dkn070 |
2008 |
* |
Pathogenicity |
On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. |
Greenstein RJ, Su L, Shahidi A, Brown ST |
PLoS One |
10.1371/journal.pone.0000516 |
2007 |
* |
Metabolism |
Interferon-gamma-dependent mechanisms of mycobacteria-induced pulmonary immunopathology: the role of angiostasis and CXCR3-targeted chemokines for granuloma necrosis. |
Aly S, Laskay T, Mages J, Malzan A, Lang R, Ehlers S |
J Pathol |
10.1002/path.2185 |
2007 |
* |
Phylogeny |
Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas. |
Florido M, Appelberg R |
Immunology |
10.1111/j.1365-2567.2006.02350.x |
2006 |
* |
Pathogenicity |
Association of rpoB mutations with rifampicin resistance in Mycobacterium avium. |
Obata S, Zwolska Z, Toyota E, Kudo K, Nakamura A, Sawai T, Kuratsuji T, Kirikae T |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2005.09.015 |
2005 |
* |
Pathogenicity |
Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics. |
Blumenthal A, Lauber J, Hoffmann R, Ernst M, Keller C, Buer J, Ehlers S, Reiling N |
Infect Immun |
10.1128/IAI.73.6.3330-3341.2005 |
2005 |
* |
Cultivation |
Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaine. |
Thornton CG, MacLellan KM, Brink TL, Passen S |
J Microbiol Methods |
10.1016/j.mimet.2003.10.020 |
2004 |
* |
Phylogeny |
Biosynthetic specificity of the rhamnosyltransferase gene of Mycobacterium avium serovar 2 as determined by allelic exchange mutagenesis. |
Maslow JN, Irani VR, Lee SH, Eckstein TM, Inamine JM, Belisle JT |
Microbiology (Reading) |
10.1099/mic.0.26565-0 |
2003 |
* |
Metabolism |
Proposed pathway for the biosynthesis of serovar-specific glycopeptidolipids in Mycobacterium avium serovar 2. |
Eckstein TM, Belisle JT, Inamine JM |
Microbiology (Reading) |
10.1099/mic.0.26528-0 |
2003 |
* |
Pathogenicity |
Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin. |
Szymanska E, Kiec-Kononowicz K |
Farmaco |
10.1016/s0014-827x(01)01194-6 |
2002 |
* |
Pathogenicity |
Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. |
Ehlers S, Benini J, Held HD, Roeck C, Alber G, Uhlig S |
J Exp Med |
10.1084/jem.194.12.1847 |
2001 |
* |
Pathogenicity |
Mycobacterium avium infection in CD14-deficient mice fails to substantiate a significant role for CD14 in antimycobacterial protection or granulomatous inflammation. |
Ehlers S, Reiling N, Gangloff S, Woltmann A, Goyert S |
Immunology |
10.1046/j.1365-2567.2001.01214.x |
2001 |
* |
Pathogenicity |
Release of monocyte chemoattractant protein (MCP)-1 by a human alveolar epithelial cell line in response to mycobacterium avium. |
Rao SP, Hayashi T, Catanzaro A |
FEMS Immunol Med Microbiol |
10.1111/j.1574-695X.2000.tb01497.x |
2000 |
* |
Stress |
Disinfectant effects of hot water, ultraviolet light, silver ions and chlorine on strains of Legionella and nontuberculous mycobacteria. |
Miyamoto M, Yamaguchi Y, Sasatsu M |
Microbios |
|
2000 |
* |
Enzymology |
Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. |
Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Muller RH, Ehlers S |
J Antimicrob Chemother |
10.1093/jac/45.1.77 |
2000 |
* |
Metabolism |
Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. |
Benini J, Ehlers EM, Ehlers S |
J Pathol |
10.1002/(SICI)1096-9896(199909)189:1<127::AID-PATH398>3.0.CO;2-S |
1999 |
* |
Metabolism |
Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. |
Ehlers S, Benini J, Kutsch S, Endres R, Rietschel ET, Pfeffer K |
Infect Immun |
10.1128/IAI.67.7.3571-3579.1999 |
1999 |
* |
Metabolism |
T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. |
Smith D, Hansch H, Bancroft G, Ehlers S |
Immunology |
10.1046/j.1365-2567.1997.00384.x |
1997 |
* |
Pathogenicity |
The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin. |
Frehel C, Offredo C, de Chastellier C |
Infect Immun |
10.1128/iai.65.7.2792-2802.1997 |
1997 |
* |
Metabolism |
Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. |
Hansch HC, Smith DA, Mielke ME, Hahn H, Bancroft GJ, Ehlers S |
Int Immunol |
10.1093/intimm/8.8.1299 |
1996 |
* |
Enzymology |
Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium. |
Escuyer V, Haddad N, Frehel C, Berche P |
Microb Pathog |
10.1006/mpat.1996.0004 |
1996 |
* |
Biotechnology |
Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. |
Sarmento AM, Appelberg R |
Infect Immun |
10.1128/iai.63.10.3759-3764.1995 |
1995 |
* |
Phylogeny |
Two markers, IS901-IS902 and p40, identified by PCR and by using monoclonal antibodies in Mycobacterium avium strains. |
Ahrens P, Giese SB, Klausen J, Inglis NF |
J Clin Microbiol |
10.1128/jcm.33.5.1049-1053.1995 |
1995 |
* |
Metabolism |
Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice. |
de Chastellier C, Frehel C, Offredo C, Skamene E |
Infect Immun |
10.1128/iai.61.9.3775-3784.1993 |
1993 |
* |
Genetics |
Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression. |
Belisle JT, Klaczkiewicz K, Brennan PJ, Jacobs WR Jr, Inamine JM |
J Biol Chem |
S0021-9258(18)82229-3 |
1993 |
* |
Pathogenicity |
Growth of Mycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth. |
Denis M |
Eur J Immunol |
10.1002/eji.1830210221 |
1991 |
* |
Enzymology |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium. |
Fernandes PB, Hardy DJ, McDaniel D, Hanson CW, Swanson RN |
Antimicrob Agents Chemother |
10.1128/AAC.33.9.1531 |
1989 |
* |
|
Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture. |
Greenstein RJ, Su L, Whitlock RH, Brown ST |
Gut Pathog |
10.1186/1757-4749-1-4 |
2009 |
* |
|
Intramacrophage growth of Mycobacterium avium during infection of mice. |
Frehel C, de Chastellier C, Offredo C, Berche P |
Infect Immun |
10.1128/iai.59.6.2207-2214.1991 |
1991 |
* |
|
The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. |
Appelberg R, Sarmento AM |
Clin Exp Immunol |
10.1111/j.1365-2249.1990.tb03288.x |
1990 |
* |